Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
- To determine the value of using piperacillin/tazobactam in reducing the cases of ESBL
producing E. coli or K. pneumoniae colonization and infection.
- To determine the acquisition rate of ESBL producing E. coli or K. pneumoniae, both pre
and post intervention in the selected medical centers.